Category: HPB & Spleen

Palliative Care’s Impact on Pancreatic Cancer: Costs Down, Outcomes Up

Researchers delved into the impact of inpatient palliative care consultation (PCC) for pancreatic cancer, revealing a game-changer. Among 175,805 patients, PCC correlated with decreased costs, shorter cumulative hospital stays, and reduced 30-day readmissions. Despite a slight uptick in PCC utilization from 2016 to 2020, the study underscores the need for heightened practitioner awareness and strategies […]

SAGES/AHPBA Guidelines for Microwave and Radiofrequency Liver Ablation in Hepatocellular Carcinoma or Colorectal Liver Metastases Under 5 cm

In the liver cancer maze, SAGES/AHPBA experts wielded microwaves and radiofrequency ablation (RFA) to guide decisions for tumors under 5 cm. Assessing outcomes and techniques, they found evidence somewhat shaky but suggested both microwave (MWA) and RFA are viable for selected patients, with laparoscopic MWA having higher risks but similar survival. However, caution blinked in […]

Revolutionizing Liver Resection: Ultrasound-Guided Compression Takes the Lead

Researchers bring a game-changer to minimal access liver surgery (MALS) for hepatocellular carcinoma (HCC). Testing the waters with laparoscopic and robotic ultrasound-guided compression anatomical resection (C-AR), they aced it with 10 patients—no post-op hiccups. This technique, known in open surgery, now waltzes into MALS, promising a bright future for HCC patients. Stay tuned for more […]

No Weekend Woes: Discharging Patients After Pancreatic Surgery on Weekends Doesn’t Raise Readmission Rates

Discharging patients on weekends following pancreatic surgery, a practice previously linked to increased mortality, was found to have no significant impact on the 30-day readmission rate. The study, encompassing 2,042 patients, revealed similar readmission rates between weekend and weekday discharges, suggesting that with careful clinical decision-making, weekend discharges after pancreatic surgery can be done safely […]

Predicting Pancreatic Complications: Machine Learning Triumphs Over Traditional Models.

Researchers crafted an innovative machine learning (ML) model for forecasting clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreaticoduodenectomy. The ML model consistently outshone the existing modified fistula risk score (MFRS) in both internal and external validations, proving its versatility and efficacy in enhancing CR-POPF prediction. This breakthrough offers a more accurate risk stratification tool, potentially […]

Optimizing Pancreatic Body Cancer Surgery: Distal Pancreatectomy with Portal Resection

For pancreatic body cancers, researchers compared distal pancreatectomy with portal vein resection (DP-PVR) to the more common pancreaticoduodenectomy with PVR. Despite DP-PVR having higher occlusion and complication rates, both approaches showed similar survival outcomes. Meticulous surgical techniques, including various reconstruction methods for DP-PVR, were crucial. The study emphasizes a surgical algorithm based on arterial and […]

Rare Hemorrhage After Distal Pancreatectomy

In the post-distal pancreatectomy (DP) landscape, researchers explored the rare territory of clinically relevant post-pancreatectomy hemorrhage (CR-PPH). Among 1,188 patients, 5.5% encountered CR-PPH, marked by increased 90-day mortality and morbidity. Prolonged operative time and co-existing postoperative pancreatic fistula independently heightened CR-PPH risk. Strikingly, the failure-to-rescue rate was significantly higher in CR-PPH cases, emphasizing the gravity […]

Pancreatic Cancer Diagnosis: FDG-PET/CT Ratio Signals Malignancy in Branch-Duct IPMNs

In the realm of pancreatic branch-duct intraductal papillary mucinous neoplasms (bd-IPMNs), spotting malignancy is tricky. However, researchers delving into 58 cases discovered a game-changer. The standardized uptake value (SUV) from FDG-PET/CT, specifically the tumor-to-blood pool ratio (TBR), emerged as a potent indicator of malignancy. Correlating significantly with histopathology, TBR proved independently significant in scenarios defining […]

Navigating Neoadjuvant Uncertainty: Ampullary and Duodenal Adenocarcinoma Management

The study delves into the uncertain territory of neoadjuvant therapy (NAT) for ampullary (AA) and duodenal adenocarcinoma (DA). Analyzing 15 retrospective studies, no clear survival differences were found between NAT and upfront surgery. While some studies hinted at benefits like increased pathologic response, overall evidence supporting NAT for AA and DA is weak. The research […]

Remote Ischemic Preconditioning Falls Short in Liver Protection Post-Hepatectomy

In a randomized trial involving 102 patients with chronic liver disease undergoing hepatectomy, remote ischemic preconditioning’s anticipated liver-protective benefits were not realized. Despite inducing preconditioning through upper extremity cycles of ischemia and reperfusion, the study showed no significant reduction in postoperative transaminase levels. The results suggest limited efficacy in mitigating ischemia-reperfusion injury, challenging the application […]